| Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins MS Park, ML Shaw, J Munoz-Jordan, JF Cros, T Nakaya, N Bouvier, ... Journal of virology 77 (2), 1501-1511, 2003 | 459 | 2003 |
| Influenza virus evades innate and adaptive immunity via the NS1 protein A Fernandez-Sesma, S Marukian, BJ Ebersole, D Kaminski, MS Park, ... Journal of virology 80 (13), 6295-6304, 2006 | 407 | 2006 |
| Recombinant Newcastle disease virus as a vaccine vector T Nakaya, J Cros, MS Park, Y Nakaya, H Zheng, A Sagrera, E Villar, ... Journal of virology 75 (23), 11868-11873, 2001 | 359 | 2001 |
| Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease MS Park, J Steel, A García-Sastre, D Swayne, P Palese Proceedings of the National Academy of Sciences 103 (21), 8203-8208, 2006 | 331 | 2006 |
| Newcastle disease virus V protein is a determinant of host range restriction MS Park, A García-Sastre, JF Cros, CF Basler, P Palese Journal of virology 77 (17), 9522-9532, 2003 | 326 | 2003 |
| A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein C Kim, DK Ryu, J Lee, YI Kim, JM Seo, YG Kim, JH Jeong, M Kim, JI Kim, ... Nature communications 12 (1), 288, 2021 | 298 | 2021 |
| The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 JE Pekar, A Magee, E Parker, N Moshiri, K Izhikevich, JL Havens, ... Science 377 (6609), 960-966, 2022 | 259 | 2022 |
| Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus A Vigil, MS Park, O Martinez, MA Chua, S Xiao, JF Cros, ... Cancer research 67 (17), 8285-8292, 2007 | 213 | 2007 |
| Duration of culturable SARS-CoV-2 in hospitalized patients with Covid-19 MC Kim, C Cui, KR Shin, JY Bae, OJ Kweon, MK Lee, SH Choi, SY Jung, ... New England Journal of Medicine 384 (7), 671-673, 2021 | 195 | 2021 |
| Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer O Ebert, K Shinozaki, C Kournioti, MS Park, A García-Sastre, SLC Woo Cancer research 64 (9), 3265-3270, 2004 | 151 | 2004 |
| Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses S Park, JI Kim, I Lee, S Lee, MW Hwang, JY Bae, J Heo, D Kim, SZ Han, ... Biochemical and biophysical research communications 440 (1), 14-19, 2013 | 119 | 2013 |
| Transmission and infectious SARS-CoV-2 shedding kinetics in vaccinated and unvaccinated individuals J Jung, JY Kim, H Park, S Park, JS Lim, SY Lim, S Bae, YJ Lim, EO Kim, ... JAMA network open 5 (5), e2213606-e2213606, 2022 | 102 | 2022 |
| Towards the application of human defensins as antivirals MS Park, JI Kim, I Lee, S Park, JY Bae, MS Park Biomolecules & therapeutics 26 (3), 242, 2018 | 91 | 2018 |
| A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome D Kim, S Kim, J Park, HR Chang, J Chang, J Ahn, H Park, J Park, N Son, ... Nature communications 12 (1), 5120, 2021 | 75 | 2021 |
| Prevalence of multiple sclerosis in Korea NH Kim, HJ Kim, HK Cheong, BJ Kim, KH Lee, EH Kim, EA Kim, S Kim, ... Neurology 75 (16), 1432-1438, 2010 | 70 | 2010 |
| Salinomycin inhibits influenza virus infection by disrupting endosomal acidification and viral matrix protein 2 function Y Jang, JS Shin, YS Yoon, YY Go, HW Lee, OS Kwon, S Park, MS Park, ... Journal of virology 92 (24), 10.1128/jvi. 01441-18, 2018 | 68 | 2018 |
| Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells LW Leung, MS Park, O Martinez, C Valmas, CB López, CF Basler Immunology and cell biology 89 (7), 792-802, 2011 | 64 | 2011 |
| The anti-influenza virus effect of Phellinus igniarius extract S Lee, JI Kim, J Heo, I Lee, S Park, MW Hwang, JY Bae, MS Park, HJ Park, ... Journal of microbiology 51, 676-681, 2013 | 61 | 2013 |
| N-linked glycosylation in the hemagglutinin of influenza A viruses JI Kim, MS Park Yonsei medical journal 53 (5), 886, 2012 | 60 | 2012 |
| Specific detection of influenza A and B viruses by CRISPR-Cas12a-based assay BJ Park, MS Park, JM Lee, YJ Song Biosensors 11 (3), 88, 2021 | 59 | 2021 |
